MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 10-31-2025
Butterfly Network Accounts Payables 2011-2026 | BFLY
Accounts payable — are the obligations of an organization to other legal entities or individuals that arise in cases when the company has acquired goods or services on deferred payment terms, has not paid taxes and fees, has wage arrears to employees, or has received loans and other liabilities. Accounts payable arise when an organization has already received some benefit but has not yet paid for it.Main types of accounts payable
| Type of liability | Example |
|---|---|
| To suppliers and contractors | Goods received but not yet paid for |
| Taxes and fees | VAT, income tax, etc., not paid on time |
| Salaries | Employee wages not paid |
| To budgets | Insurance contributions to funds not paid |
| To founders | Founders provided borrowed funds |
| To banks | Overdue loan payments |
| Other | Fines, penalties, forfeits, customer prepayments, etc. |
Impact on the company's financial performance
- Liquidity and solvency
Accounts payable are part of short-term liabilities, so they affect liquidity ratios - Financial stability
The higher the share of borrowed funds (including accounts payable), the lower the company's level of independence - Capital turnover
Moderate accounts payable can positively affect working capital by allowing the company to use “free” financing from suppliers (payment deferrals) - Risks and reputation
Large and especially overdue accounts payable may indicate financial difficulties. This can deter investors, partners, and lenders, and at a critical level of debt and lack of resources to repay it, bankruptcy proceedings may be initiated
Annual Accounts Payables Butterfly Network
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4.25 M | 5.09 M | 7.21 M | 5.8 M | 16.4 M | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 16.4 M | 4.25 M | 7.75 M |
Quarterly Accounts Payables Butterfly Network
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.31 M | 3.32 M | 2.28 M | 3.65 M | 4.51 M | 5.81 M | 8.1 M | 8.39 M | 5.43 M | 7.21 M | 2.68 M | - | 2.68 M | 5.8 M | 5.02 M | 5.26 M | 5.27 M | 16.4 M | 16.4 M | 16.4 M | 16.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 16.4 M | 2.28 M | 7.22 M |
Accounts Payables of other stocks in the Medical devices industry
| Issuer | Accounts Payables | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Axonics Modulation Technologies
AXNX
|
9.07 M | - | - | $ 3.31 B |  USA |
 |
Xtant Medical Holdings
XTNT
|
7.92 M | $ 0.55 | -2.31 % | $ 73.5 M | USA |
 |
Dynatronics Corporation
DYNT
|
3.4 M | - | 14.99 % | $ 929 K | USA |
 |
Aziyo Biologics
AZYO
|
4.79 M | - | 1.37 % | $ 20.5 M | USA |
 |
Acutus Medical
AFIB
|
2.76 M | - | -26.83 % | $ 2.62 M | USA |
 |
Zimmer Biomet Holdings
ZBH
|
195 M | $ 88.57 | -0.65 % | $ 18 B | USA |
 |
Allied Healthcare Products
AHPI
|
1.21 M | - | 3.58 % | $ 2.21 M | USA |
 |
Alphatec Holdings
ATEC
|
40.9 M | $ 10.93 | -5.12 % | $ 1.64 B | USA |
 |
Conformis
CFMS
|
4.16 M | - | - | $ 16.4 M | USA |
 |
Accuray Incorporated
ARAY
|
34 M | $ 0.4 | 4.21 % | $ 41.1 M | USA |
 |
Insulet Corporation
PODD
|
75 M | $ 208.22 | -4.53 % | $ 14.6 B | USA |
 |
Cardiovascular Systems
CSII
|
14.4 M | - | 0.15 % | $ 844 M | USA |
 |
Second Sight Medical Products
EYES
|
1.03 M | - | -0.97 % | $ 54.4 M | USA |
 |
Apollo Endosurgery
APEN
|
7.42 M | - | - | $ 475 M | USA |
 |
Avinger
AVGR
|
777 K | - | -20.74 % | $ 369 K | USA |
 |
CONMED Corporation
CNMD
|
93.6 M | $ 34.58 | -5.62 % | $ 1.07 B | USA |
 |
NanoVibronix
NAOV
|
47 K | - | - | $ 1.08 M | USA |
 |
Cytosorbents Corporation
CTSO
|
3.34 M | $ 0.59 | -1.18 % | $ 32.1 M | USA |
 |
Aethlon Medical
AEMD
|
535 K | $ 2.15 | -5.29 % | $ 3.36 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
228 M | $ 79.34 | -3.36 % | $ 46.4 B | USA |
 |
BIOLASE
BIOL
|
6.06 M | - | -13.19 % | $ 166 K | USA |
 |
AdaptHealth Corp.
AHCO
|
352 M | $ 11.2 | -1.84 % | $ 1.51 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
18.8 M | $ 15.52 | -5.08 % | $ 364 M | USA |
 |
Invacare Corporation
IVC
|
105 M | - | - | $ 24.7 M | USA |
 |
Ra Medical Systems
RMED
|
92 K | - | 10.0 % | $ 610 K | USA |
 |
Myomo
MYO
|
1.51 M | $ 0.7 | 2.32 % | $ 29.3 M | USA |
 |
Penumbra
PEN
|
34.7 M | $ 335.1 | -0.39 % | $ 13 B | USA |
 |
Inspire Medical Systems
INSP
|
36.6 M | $ 50.13 | -0.63 % | $ 1.47 B | USA |
 |
Pulmonx Corporation
LUNG
|
3.9 M | $ 1.17 | -5.65 % | $ 47.6 M | USA |
 |
Cutera
CUTR
|
19.8 M | - | -10.19 % | $ 1.99 M | USA |
 |
Eargo
EAR
|
6.5 M | - | - | $ 10.2 M | USA |
 |
NuVasive
NUVA
|
20.3 M | - | - | $ 2.07 B | USA |
 |
Nevro Corp.
NVRO
|
24.5 M | - | - | $ 217 M | USA |
 |
Surgalign Holdings
SRGA
|
7.7 M | - | -32.98 % | $ 1.68 M | USA |
 |
STRATA Skin Sciences
SSKN
|
3.42 M | - | - | $ 6.6 M | USA |
 |
GBS
GBS
|
1.47 M | - | -0.57 % | $ 7.12 M | USA |
 |
AxoGen
AXGN
|
2.89 M | $ 31.28 | -3.01 % | $ 1.44 B | USA |